Company & Sponsor Intelligence
University of Kansas
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting1
Completed2
Countries1
Therapeutic footprint
autismepilepsysubstance_use
Indexed studies
NCT00680121High Dose Vitamin B1 to Reduce Abusive Alcohol Use
substance_use · United StatesPHASE4
substance_use · United StatesPHASE4
NCT00347152Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT05799599Peer Interventions for Preschoolers With Autism
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →